Health Atlas
Menu
Evidence-led reference

Prevention & care

Shared decision making: evidence, personal priorities and what decision aids can do

6 sources · Latest source check 2026-10-13 UTC
On this page

Shared decision making combines discussion of healthcare options with what matters to the patient. A clinician brings relevant clinical information, while the person describes priorities and practical circumstances. A decision aid can support that conversation; it does not make the patient’s choice automatically.[1]

Different supports answer different needs

Different supports answer different needs
CategoryMeaningBoundary
Shared discussionExchange of options, evidence and prioritiesCan need more than one visit[2]
Patient decision aidStructured help comparing options and thinking about valuesDoes not replace clinical interpretation[2]
Decision coachingAdditional support to work through the decisionAdded benefit over an aid alone remains uncertain[6]
Evidence-quality criteriaExpectations for current, critically appraised informationA polished interface is not enough[3]

The elements can be revisited

AHRQ’s SHARE conversation guide includes seeking participation, comparing options, assessing values, reaching a decision and evaluating it. The elements can be used in different orders and repeated. It prompts clinicians to check understanding and discuss whether practical barriers may prevent following the chosen plan. That is different from asking someone to select from a menu without an explanation. An aid or a worksheet is useful only in the context of the actual options and a conversation about what matters.[2]

A preference is relevant information

AHRQ’s model describes dialogue about benefits, harms, risks and patient priorities. People can value outcomes differently, or face different constraints on implementing a plan. Clarifying these differences helps identify questions needing attention; it does not make every requested intervention clinically suitable. A clinician’s recommendation and a patient’s values can both be discussed. The model is professional communication guidance, rather than proof that a particular choice is medically optimal or that the patient must decide without support.[1]

Check what supports the comparison

The 2021 IPDAS evidence update says high-quality patient decision aids should be grounded in comprehensive, current syntheses of critically appraised evidence. Ask which decision the tool addresses, which options it includes, where estimates come from and when the evidence was updated. This standard does not mean every tool carrying a decision-aid label meets it. The update was inspected through original indexed excerpts, not an independent full-text appraisal. An appealing presentation and a transparent evidence basis are separate qualities.[3]

Evidence & uncertainty

A 2024 Cochrane review found improvements in knowledge, risk perception and participation across many treatment and screening decisions. Its evidence concerns tested decision-support tools and outcomes, rather than proving that any webpage or questionnaire produces the same benefit.[4]

Selected-source overview · Independent review pending

Published questions

Will a patient decision aid tell me the single right treatment?

Selected-source overview · Independent review pending. Read the evidence context.

It supports comparison and reflection on priorities, alongside discussion with the clinician. AHRQ frames this as choosing together, including checking understanding and what may get in the way. It does not automate the choice.[2]

Evidence behind this answer
  • The SHARE Approach: Conversation Starters

    agency explanation · 2024
    Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal · Five flexible/repeated elements; support, understanding and implementation

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Must the SHARE elements happen once in a fixed order?

Selected-source overview · Independent review pending. Read the evidence context.

No. The conversation guide allows different orders and repetition. Questions, understanding and the practical fit of a plan may need to be revisited.[2]

Evidence behind this answer
  • The SHARE Approach: Conversation Starters

    agency explanation · 2024
    Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal · Five flexible/repeated elements; support, understanding and implementation

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Are personal priorities relevant even when trial results exist?

Selected-source overview · Independent review pending. Read the evidence context.

Yes. AHRQ’s model combines evidence about options with what matters to the person. Priorities do not erase clinical constraints, but they help frame a supported decision.[1]

Evidence behind this answer
  • The SHARE Approach

    agency explanation · Date not stated
    Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal · Clinician-led discussion of options, risks and what matters; reviewed February 2026

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does calling a website a decision aid prove its evidence is current?

Selected-source overview · Independent review pending. Read the evidence context.

No. IPDAS sets expectations for comprehensive, current and critically appraised evidence. Check the actual tool’s source basis and update information rather than relying on its label or appearance.[3]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Do aids necessarily improve later medicine adherence?

Selected-source overview · Independent review pending. Read the evidence context.

No such universal result is established. The atrial-fibrillation follow-up found no significant adherence difference with the tested conversation tool. That narrow finding is not proof that all tools are ineffective.[5]

Evidence behind this answer

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Has adding decision coaching been proven better than an aid alone?

Selected-source overview · Independent review pending. Read the evidence context.

The scoping review found inadequate evidence for that particular comparison. Benefits against usual care do not establish superiority over an aid already being used.[6]

Evidence behind this answer
  • Guidance and/or Decision Coaching with Patient Decision Aids

    scoping reviews · 2021
    Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal · Original abstract: 21 RCTs; usual-care comparison versus uncertain added benefit over aid alone

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

The large review supports decision outcomes, with limits

The 2024 Cochrane update included 209 studies and 107,698 adults across 71 decisions. Its search extended through March 2022. Knowledge, accurate risk perceptions and participation improved compared with usual care, while effects on choosing particular options differed by decision. Evidence about adherence and downstream costs or resource use remained inadequate, and no studies measured preference-linked health outcomes. The aids, comparators and settings also varied. These findings support better-informed discussions, not a universal instruction to choose more treatment or a guarantee of better long-term health.[4]

A process improvement may not change adherence

A randomized anticoagulation conversation-tool trial enrolled 922 evaluable encounters involving people with atrial fibrillation considering or reviewing treatment. At approximately ten months, 814 had pharmacy and clinical follow-up. The report found no significant differences in primary or secondary adherence or clinical safety outcomes between the aid and usual-care groups. A null finding is not proof of exact equivalence, and this condition-specific tool is not every possible decision aid. It makes the distinction between improving a decision process and changing later treatment outcomes concrete.[5]

Additional support has its own comparison

The 2021 IPDAS scoping reviews identified 21 randomized trials of decision coaching. Coaching with an aid could improve knowledge compared with usual care, but the authors found inadequate evidence about its added effectiveness compared with an aid alone. Coaching, the aid and the comparator must therefore be identified separately. Combining supports is not automatically proven superior to every simpler alternative. The review and the larger Cochrane synthesis may include overlapping underlying work, so their counts should not be added as independent replications.[6]

References

  1. The SHARE Approach

    Agency explanation

    AHRQ · Content/publication date: not stated
    Accessed: 2026-10-13 UTC · Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal
    Cited sections: Clinician-led discussion of options, risks and what matters; reviewed February 2026

  2. The SHARE Approach: Conversation Starters

    Agency explanation

    AHRQ · Content/publication date: 2024
    Accessed: 2026-10-13 UTC · Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal
    Cited sections: Five flexible/repeated elements; support, understanding and implementation

  3. Basing Information on Comprehensive, Critically Appraised, and Up-to-Date Syntheses of the Scientific Evidence: An Update from the International Patient Decision Aid Standards

    Evidence and standards review

    Hoffmann and colleagues / Medical Decision Making · Content/publication date: 2021
    Accessed: 2026-10-13 UTC · Original indexed official or research passages inspected; direct full-text access unavailable or not independently appraised
    Cited sections: Original indexed abstract: evidence-currency criteria and source-transparency expectations

    Direct PubMed output lacked the abstract.

  4. Decision aids for people facing health treatment or screening decisions

    Systematic review

    Stacey and colleagues / Cochrane · Content/publication date: 2024
    Accessed: 2026-10-13 UTC · Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal
    Cited sections: Selected methods/results/discussion ; 209 studies; search March 2022; decision outcomes and gaps

  5. Effect of Shared Decision-Making for Stroke Prevention on Treatment Adherence and Safety Outcomes

    Randomized trial followup

    Noseworthy and colleagues / JAHA · Content/publication date: 2022
    Accessed: 2026-10-13 UTC · Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal
    Cited sections: Original abstract: 922 encounters, 814 follow-up, ten-month adherence and safety outcomes

  6. Guidance and/or Decision Coaching with Patient Decision Aids

    Scoping reviews

    Rahn and colleagues / Medical Decision Making · Content/publication date: 2021
    Accessed: 2026-10-13 UTC · Selected relevant original official passages or original methods/results inspected; no independent full-document appraisal
    Cited sections: Original abstract: 21 RCTs; usual-care comparison versus uncertain added benefit over aid alone

Scope & review

Population
General readers; study populations, eligibility and jurisdiction are specified in the explanation
Exposure or intervention
Shared decision making
Comparison
Structured aids versus varied usual care; coaching plus aids versus an aid alone; decision-process outcomes versus adherence or later clinical outcomes
Outcomes
Understanding care choices, communication, documentation and source-specific findings
Timeframe
Dated guidance and selected research; not an individual clinical, financial or legal determination
Jurisdiction
US insurance and advance-planning examples; UK consent guidance and international decision-support research are labeled separately. Local law and plan requirements differ.

Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-13 UTC: Added an educational guide to healthcare choices, with selective source access and qualified-review gaps recorded.

What this article still leaves open

  • Which tools remain current and accessible for the actual decision?
  • Which decision supports improve preference-linked outcomes and reduce access inequalities in real practice?
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.